Synthesis and biological activity of selective pipecolic acid-based TNF-α converting enzyme (TACE) inhibitors
- 20 May 2002
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (10), 1387-1390
- https://doi.org/10.1016/s0960-894x(02)00183-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.Nature Structural & Molecular Biology, 1999
- The reaction of lithium trimethylsilyldiazomethane with pyroglutamates — a facile synthesis of 6-diazo-5-oxo-norleucine and derivativesTetrahedron Letters, 1998
- Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzymeProceedings of the National Academy of Sciences of the United States of America, 1998
- Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-αNature, 1997
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Preparation of (2S,4R)-4-Hydroxypipecolic Acid and DerivativesThe Journal of Organic Chemistry, 1996
- A High Throughput Fluorogenic Substrate for Interstitial Collagenase (MMP-1) and Gelatinase (MMP-9)Analytical Biochemistry, 1993
- Synthesis of 5-oxo-l-pipecolic acid derivatives by rhodium(II) acetate catalyzed cyclization of diazoketonesTetrahedron Letters, 1992